Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sree Rayalaseema Hi-Strength Hypo's EBIT per Share for the
three
months ended in Mar. 2026 was ₹14.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹71.79.
During the past 12 months, the average EBIT per Share Growth Rate of Sree Rayalaseema Hi-Strength Hypo was -5.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -20.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -4.20% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 15.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Sree Rayalaseema Hi-Strength Hypo's EBIT per Share or its related term are showing as below:
BOM:532842'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -27 Med: 8.6 Max: 46
Current: -20
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sree Rayalaseema Hi-Strength Hypo was 46.00% per year. The lowest was -27.00% per year. And the median was 8.60% per year.
BOM:532842's 3-Year EBIT Growth Rate is ranked worse than 75.69% of 1337
companies
in the Chemicals industry
Industry Median: -0.9
vs BOM:532842: -20.00
Sree Rayalaseema Hi-Strength Hypo (BOM:532842) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Sree Rayalaseema Hi-Strength Hypo EBIT per Share Related Terms
Sree Rayalaseema Hi-Strength Hypo EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sree Rayalaseema Hi-Strength Hypo EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹71.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sree Rayalaseema Hi-Strength Hypo (BOM:532842) has a EBIT per Share of ₹71.79 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sree Rayalaseema Hi-Strength Hypo and its competitors. According to the industry distribution chart, Sree Rayalaseema Hi-Strength Hypo ranks #1012 out of 1337 companies in the Chemicals industry, placing it in the top 75.7%.
Is Sree Rayalaseema Hi-Strength Hypo's EBIT per Share too high?
Sree Rayalaseema Hi-Strength Hypo's current EBIT per Share is ₹71.79. Based on the distribution chart, Sree Rayalaseema Hi-Strength Hypo ranks #1012 out of 1337 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Sree Rayalaseema Hi-Strength Hypo has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sree Rayalaseema Hi-Strength Hypo's EBIT per Share compare to DOW?
According to the Chemicals industry distribution chart, Sree Rayalaseema Hi-Strength Hypo ranks #1012 out of 1337 companies for EBIT per Share. This places Sree Rayalaseema Hi-Strength Hypo in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Sree Rayalaseema Hi-Strength Hypo and its competitors. Sree Rayalaseema Hi-Strength Hypo's current EBIT per Share is ₹71.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sree Rayalaseema Hi-Strength Hypo stock overvalued right now?
Based on GuruFocus' analysis, Sree Rayalaseema Hi-Strength Hypo (BOM:532842) is currently considered Fairly Valued. The stock's GF Value™ is ₹457.77, compared to a current price of ₹499.85 — trading 9.2% above its estimated fair value. The current EBIT per Share is ₹71.79. Sree Rayalaseema Hi-Strength Hypo's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Sree Rayalaseema Hi-Strength Hypo (BOM:532842), the current EBIT per Share is ₹71.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sree Rayalaseema Hi-Strength Hypo (BOM:532842) Overvalued in 2026?
Based on GuruFocus' analysis, Sree Rayalaseema Hi-Strength Hypo stock appears to be overvalued.
The current stock price of ₹499.85 is trading 9.2% above its estimated GF Value™ of ₹457.77.
GuruFocus considers Sree Rayalaseema Hi-Strength Hypo to be Fairly Valued.
Key valuation signals for BOM:532842:
EBIT per Share: ₹71.79
GF Value™: ₹457.77 vs. price of ₹499.85 (9.2% above fair value)
No single metric tells the full story. See the BOM:532842 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sree Rayalaseema Hi-Strength Hypo Ltd is an India-based company engaged in manufacturing inorganic chemicals and generating power through wind and thermal. The company has three reportable segments: Chemical manufacturing and Power Generation, and Trading in Coal, of which Chemical manufacturing segment. The company's products include Sulphuric acid, Chlorosulphonic acid, Chloramine, oleum, Hydrochloric acid, Monochloro acetic acid, Sodium dichloro isocyanurate, Hydrogen gas, Aluminium sulfate, Stable bleaching powder, Sodium hydride, Sodium methoxide powder, Sodium methoxide solution, and Water treatment chemicals.
68GF Score
Get the complete analysis for BOM:532842
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532842 has been successfully added to your 
